Angiotensin I/II (1-7) (human) Acetate 10 mg/vial (Clinalfa basic)

U-1280

A selection of publications is listed below. For a comprehensive list please contact us.

 

All information is compiled to the best of our knowledge. We cannot be made liable for any possible errors or misprints.

Clinalfa

Reviews

2013

van Twist, D. J., Houben, A. J., de Haan, M. W., Mostard, G. J., Kroon, A. A. and de Leeuw, P. W.
Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
Hypertension 62, 789-793 (2013)
Abstract

 

2009

Höcht, C., Mayer, M. and Taira, C. A.
Therapeutic perspectives of angiotensin-(1-7) in the treatment of cardiovascular disease.
Open Pharmacology J. 3, 21-31 (2009)

 

2008

Ager, E. I., Neo, J. and Christophi, C.
The renin-angiotensin system and malignancy.
Carcinogenesis 29, 1675-1684 (2008)
Abstract

 

2007

Schindler, C., Bramlage, P., Kirch, W. and Ferrario, C. M.
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.
Vasc. Health Risk Manag. 3, 125-137 (2007)
Abstract

Trask, A. J. and Ferrario, C. M.
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
Cardiovasc. Drug Rev. 25, 162-174 (2007)
Abstract

 

2005

Ferrario, C. M., Trask, A. J. and Jessup, J. A.
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.
Am. J. Physiol. Heart Circ. Physiol. 289, H2281-2290 (2005)
Abstract

 

Others

2010

Cook, K. L., Metheny-Barlow, L. J., Tallant, E. A. and Gallagher, P. E.
Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.
Cancer Res. 70, 8319-8328 (2010)
Abstract

Costa, M. A., Lopez Verrilli, M. A., Gomez, K. A., Nakagawa, P., Pena, C., Arranz, C. and Gironacci, M. M.
Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.
Am. J. Physiol. Heart Circ. Physiol. 299, H1205-1211 (2010)
Abstract

 

2009

Kluskens, L. D., Nelemans, S. A., Rink, R., de Vries, L., Meter-Arkema, A., Wang, Y., Walther, T., Kuipers, A., Moll, G. N. and Haas, M.
Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog.
J. Pharmacol. Exp. Ther. 328, 849-854 (2009)
Abstract

Petty, W. J., Miller, A. A., McCoy, T. P., Gallagher, P. E., Tallant, E. A. and Torti, F. M.
Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.
Clin. Cancer Res. 15, 7398-7404 (2009)
Abstract

 

2007

Blood pressure drug shows potential as lung cancer treatment.
Eurekalert (2007)

Benter, I. F., Yousif, M. H., Cojocel, C., Al-Maghrebi, M. and Diz, D. I.
Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction.
Am. J. Physiol. Heart Circ. Physiol. 292, H666-672 (2007)
Abstract

Menon, J., Soto-Pantoja, D. R., Callahan, M. F., Cline, J. M., Ferrario, C. M., Tallant, E. A. and Gallagher, P. E.
Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.
Cancer Res. 67, 2809-2815 (2007)
Abstract

 

2001

Wilsdorf, T., Gainer, J. V., Murphey, L. J., Vaughan, D. E. and Brown, N. J.
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.
Hypertension 37, 1136-1140 (2001)
Abstract

  

2000

Ueda, S., Masumori-Maemoto, S., Ashino, K., Nagahara, T., Gotoh, E., Umemura, S. and Ishii, M.
Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.
Hypertension 35, 998-1001 (2000)
Abstract

 

1999

Davie, A. P. and McMurray, J. J.
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Hypertension 34, 457-460 (1999)
Abstract